Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma By Ogkologos - April 20, 2026 143 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source RELATED ARTICLESMORE FROM AUTHOR Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers MOST POPULAR Targeted Drug Erdafitinib Benefits Some Patients with Advanced Bladder Cancer August 9, 2019 11 Children Orphaned and Unable to Pay for Funeral After Their... April 25, 2019 What to Know About Kidney Cancer Genetic Conditions and Genetic Counseling June 9, 2021 5-Year-Old Boy Meets Generous Stem Cell Donor Who Cured Him October 13, 2021 Load more HOT NEWS ASCO20 Virtual Research Round Up Podcast: Leukemia, Colorectal Cancer, and Lung... Can Using Essential Oils Help Treat Cancer and Its Side Effects? Mississippi Teen Uses Make-A-Wish Grant To Feed Homeless In His Community Aspartame and cancer – sweet nothings?
